JPM vs TMO: Which Is the Better Buy?
Side-by-side comparison of JPMorgan Chase & Co. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-14.
JPMorgan Chase & Co. · Financial Services
$334.53
+45.0% upside to fair value
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
JPM has more upside to fair value
(+45.0%).
JPM trades at a lower forward P/E
(14.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JPM |
TMO |
| Current Price |
$334.53 |
$464.61 |
| Fair Value Estimate |
$485.07 |
$498.27 |
| Upside to Fair Value |
+45.0%
|
+7.2%
|
| Market Cap |
$896.4B |
$172.7B |
| Forward P/E |
14.3x
|
25.2x
|
| EV / EBITDA |
12.4x
|
19.1x
|
| Price / Sales |
5.4x
|
3.8x
|
| Price / FCF |
6.4x
|
25.6x
|
| Revenue Growth YoY |
-168.4%
|
+6.2%
|
| Gross Margin |
78.6%
|
39.4%
|
| Operating Margin |
33.7%
|
17.8%
|
| Return on Equity |
17.8%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
15.72%
|
3.91%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
JPMorgan Chase & Co. operates as a leading diversified bank within the financial services sector, demonstrating a high-quality business model characterized by a strong return on equity of 17.8% and robust profitability margins including a net margin of 38.9%. Despite a significant revenue decline of 168.4% year-over-year in the most recent quarter, earnings grew by 41.2%, reflecting operational e…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
JPM |
TMO |
| Zone Low |
$363.80 |
$373.70 |
| Zone High |
$412.31 |
$423.53 |
| In Buy Zone? |
Yes
|
No
|